The Australian Securities Exchange ("ASX") has annnounced that shares of Botanix Pharmaceuticals Ltd. (ASX:BOT) have been halted at the request of the company pending news.
The company intends to make an announcement regarding clinical trial results. Shares are set to resume trading upon the release of the announcement but no later than the market open on Tuesday, July 4th.
Be sure to subscribe to our Australian cannabis newsletter so you never miss an important update. Also, don't forget to connect with The Daily Marijuana Observer on Facebook, Twitter, and Instagram.
Now Read: What does it mean when a stock is halted?
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.